DAIC

DECEMBER 26, 2023

a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter.

Ablation 59

Ablation Atrial Fibrillation Technology Cardiothoracic 59

HeartRhythm

NOVEMBER 5, 2024

Pulsed field ablation (PFA) is a safe and effective technology for catheter ablation of atrial fibrillation (AF). Multiple PFA-platforms for AF-ablation have been developed. However, evidence comparing the real-word implementation and performance of different PFA-systems is still limited.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Outcomes 40

HeartRhythm

AUGUST 21, 2024

No data have been reported on cooling characteristics and the impact of variant pulmonary vein (PV) anatomy on atrial fibrillation (AF) recurrences after POLARx cryoballoon (CB) ablation.

Anatomy 40

Anatomy Atrial Fibrillation Pulmonary Ablation 40

HeartRhythm

APRIL 30, 2024

Novel technologies and ablation techniques for identification of AF sources and personalized substrate modification may be required to improve outcomes for persistent AF.

Ablation 40

Ablation Electrophysiology Technology Outcomes 40

HeartRhythm

APRIL 30, 2024

Cryoballoon (CB) ablation is the mainstay of single-shot pulmonary vein isolation (PVI). However, these two technologies have not been compared. A radiofrequency balloon (RFB) catheter has recently emerged as an alternative.

Pulmonary 40

Pulmonary Ablation Technology Outcomes 40

AMS Cardiology

MARCH 31, 2025

Catheter Ablation: This minimally invasive procedure is now the gold standard for many AFib patients. Pulsed Field Ablation (PFA) : PFA uses controlled electrical fields to target abnormal heart tissue with a reduced risk of damaging surrounding structures like the esophagus or nerves. Other options are typically recommended first.

Atrial Fibrillation 52

Atrial Fibrillation AFIB Heart Rhythm Blood Pressure 52

HeartRhythm

APRIL 30, 2024

Pulmonary vein (PV) isolation is the cornerstone of radiofrequency (RF) ablation for atrial fibrillation (AF). PV reconnection is the most common cause of recurrent AF following an ablation procedure. Advances in catheter technology, ablation techniques, and ablation lesion metrics have resulted in improved PV isolation durability.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Pulmonary Technology 40

HeartRhythm

APRIL 30, 2024

Recent advancements in radiofrequency ablation (RFA) technology utilize improvements in contact force-sensing (CF) technology, irrigation, and temperature monitoring to improve procedural metrics and outcomes.

Ablation 40

Ablation Technology Outcomes 40

HeartRhythm

APRIL 30, 2024

Recent advancements in pulsed field ablation (PFA) technology offer a potential avenue for the secure performance of LAA electrical isolation (LAAEI). The left atrial appendage (LAA) is increasingly recognized as a critical focus for initiating and maintaining atrial arrhythmias.

Ablation 40

Ablation Technology Arrhythmia Outcomes 40

HeartRhythm

APRIL 30, 2024

Pulsed-field ablation (PFA) is becoming increasingly relevant in the field of electrophysiology. Besides single-shot PFA devices for pulmonary vein isolation (PVI), point-by-point PFA is also gaining importance due to many possible applications. Data on the use is sparse, especially for atrial tachycardia (AT).

Tachycardia 40

Tachycardia Ablation Electrophysiology Technology 40

HeartRhythm

APRIL 30, 2024

We have employed digital twin technology to perform extra pulmonary vein (PV) ablation in patients with non-paroxysmal atrial fibrillation (AF). We reported that high dominant frequency (DF) site ablation improved rhythm outcomes, but high maximal slope of action potential restitution curve (Smax) site ablation did not.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Pulmonary 40

HeartRhythm

APRIL 30, 2024

Introduction: Pulsed Field Ablation (PFA) technologies are being studied in a number of clinical trials, many with strict inclusion/exclusion criteria-typically younger patients with less comorbidities undergoing de-novo PVI procedures.

Ablation 40

Ablation Atrial Fibrillation Arrhythmia Technology 40

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Background The newly introduced nonthermal pulsed field ablation (PFA) is a promising technology to achieve fast pulmonary vein isolation (PVI) with high acute success rates and good safety features. Data comparing PFA to VHPSD-PVI is lacking. Two tamponades occurred in the PFA while in VHPSD two pts suffered groin bleedings.

Ablation 40

Ablation Pulmonary Arrhythmia Atrial Fibrillation 40

Journal of Cardiovascular Electrophysiology

MARCH 3, 2024

However, this technique was developed at a time when using power-controlled ablation catheters with conventional power ranges was the norm. There has been increased adoption of a high-power and very high-power short-duration ablation practice propelled by the availability of the temperature-controlled radiofrequency QDOT MICRO catheter.

Ablation 40

Ablation Pulmonary Technology Outcomes 40

Journal of Cardiovascular Electrophysiology

MARCH 4, 2024

This information allows more focused intracardiac mapping (activation map during VT, center figure) and accelerates the ablation process, reducing time to first ablation, overall procedure duration (right figure), and fluoroscopy use. reduction in time to ablation (133 ± 48 vs. 165 ± 49 min, p  = 0.02), a 22.6% vs. 33.2 ± 18.0

Arrhythmia 40

Arrhythmia Ablation Tachycardia Atrial Fibrillation 40

Journal of Cardiovascular Electrophysiology

JANUARY 10, 2024

Abstract Introduction Despite advanced ablation strategies and major technological improvements, treatment of persistent atrial fibrillation (AF) remains challenging and the underlying pathophysiology is not fully understood. Randomized studies are necessary to evaluate long-term efficacy of dispersion-guided ablation using AI.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outpatient Arrhythmia 40

DAIC

JANUARY 29, 2025

ii The DEFINE AFib clinical study enrolled 973 patients using an app-based enrollment feature and characterized the impact of AF burden on patient outcomes and quality of life. By 2030, approximately 12.2 million people in the U.S. will have AF, an irregular and potentially dangerous heart rhythm. 2024, May 15).

AFIB 52

AFIB Atrial Fibrillation Quality of Life Heart Rhythm 52

HeartRhythm

MAY 15, 2024

In the past decade, major advances were made in catheter ablation for arrhythmias and implantation of cardiac implantable electronic devices.1 1 Catheter ablation for atrial fibrillation (AF) and ventricular tachycardia (VT) has become the standard of care for many patients presenting with these arrhythmias.2–4

Electrophysiology 40

Electrophysiology Atrial Fibrillation Ablation Arrhythmia 40

HeartRhythm

APRIL 30, 2024

Adjunctive ablation targeting LVAs, has been reported to improve outcomes. Omnipolar technology (OT) overcomes many limitations of BiV mapping, however there is little data on equivalent OT thresholds. Left atrial (LA) low voltage area (LVA) burden correlates with AF recurrence risk post pulmonary vein isolation.

Technology 40

Technology Pulmonary Ablation Outcomes 40

Dr. S. Venkatesan MD

MAY 15, 2024

HOT-CAFE (2004) Now, in 2020s with modalities like ablation, the choice is being pushed toward Pro-rhythm control. (Of RAFT AF (Again equivocal) With emerging new technologies, scientists are trying whether more safer methods like cryoablation or pulse-filed ablation would beat the rate control with drugs. EAST-AFNET (2020) 2.CASTLE

Ablation 52

Ablation Atrial Fibrillation Technology Cardiovascular Disease 52

DAIC

FEBRUARY 29, 2024

This year’s theme, “Advancing Cardiovascular Care for All” brings the latest practice-changing breakthroughs, along with top experts debating and discussing outcomes of highly-anticipated clinical trials. 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

SoftCath

DECEMBER 2, 2021

Even with success accomplished through extensive propagation of advanced technologies, there is substantial opportunity to advance medical techniques. Discussing further, Catheterization Laboratory, also called Cath Lab, is a medical examination room where angiogram, angioplasty, ablation, and implantation of pacemaker are carried out.

Technology 52

Technology Innovation Catheterization Laboratory COVID-19 52

Vector Remote

MARCH 9, 2023

RPM solutions are improving healthcare outcomes and helping patients lead healthier lives. With effective management and use, RPM can provide clinicians with the tools to improve patient outcomes and deliver better quality care. What is Cardiac Remote Patient Monitoring Software ?

Heart Failure 52

Heart Failure Patient Care Heart Rhythm Hypertension 52

Cardiomatics

JANUARY 5, 2023

It is a cloud-based AI Holter ECG analysis technology which can analyze signals recorded in various data formats regardless of the length of the ECG recording. The medical-grade system from Cardiomatics which we are using ensures high-quality and trusted outcomes based on accurate algorithms ,” said Prof.

Atrial Fibrillation 52

Atrial Fibrillation Hospital Article Technology 52

Society of Thoracic Surgeons - Allied Health

FEBRUARY 14, 2023

Leveraging Technology to Improve CABG Outcomes Viviany Taqueti, MD, MPH (Boston, MA, USA) 9:20 a.m. Women and CABG: A Comparison of Graft Conduit Outcomes from the National Adult Cardiac Surgery Audit Database Arnaldo Dimagli, MD (New York, NY, USA) 11:50 a.m. Panel Discussion 8:56 a.m. Panel Discussion 9:55 a.m. –

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Atrial Fibrillation Outcomes Stent 52

DAIC

MARCH 27, 2025

1,2 People living with AFib face an increased risk of stroke, heart failure and death, and many rely on cardiac ablation to treat the condition effectively. of veins during ablation procedures with far fewer energy applications than on-market competitive PFA systems. 3 Following approval, initial cases were completed by Prof.

Ablation 52

Ablation AFIB Atrial Fibrillation Electrophysiology 52

DAIC

FEBRUARY 14, 2025

In particular, the study showed superiority in the percentage of patients that achieved freedom from atrial fibrillation (AF) with or without anti-arrhythmic drugs at 12 months after a tailored cardiac ablation guided by AI in combination with PVI when compared to PVI alone. tim.hodson Fri, 02/14/2025 - 09:57 Feb.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Technology Pulmonary 52

DAIC

MAY 18, 2024

During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.

Heart Rhythm 105

Heart Rhythm Atrial Fibrillation Ablation Quality of Life 105

DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Our mission to combat complex heart rhythm diseases relies on optimizing interoperability.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

DAIC

FEBRUARY 12, 2025

cardiac electrophysiologist, performed one of the nations first procedures to control atrial fibrillation (Afib) using a new type of catheter that can deliver two different types of electrical energy or ablation to destroy the damaged part of the heart that is triggering the abnormal heartbeats. tim.hodson Wed, 02/12/2025 - 15:04 Feb.

AFIB 52

AFIB Research Ablation Atrial Fibrillation 52

DAIC

MARCH 5, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). iii] The study reported a low fluoroscopy time of 7.8

Ablation 59

Ablation Atrial Fibrillation Atrial Flutter Pulmonary 59

DAIC

MAY 3, 2024

Clinical trials and innovative technology took center stage during the month of April, racking up some record number views. New Study Reveals 65 and Older Population Lowered Blood Pressure, Cholesterol and Weight Using Mobile Technology 2. Shorten the Blanking Period After Atrial Fibrillation Ablation, Experts Say 4.

Angioplasty 105

Angioplasty Blood Pressure Heart attacks Heart Attack 105

DAIC

JUNE 25, 2024

HHNM will use the Allia IGS Pulse system in its cardiac electrophysiology (EP) lab to plan, guide and monitor the outcomes of electrophysiological procedures, such as cardiac ablations, cardiac catherizations, transcatheter aortic valve replacements, balloon and coronary angioplasties and more.

Electrophysiology 105

Electrophysiology Hospital Aortic valve Heart Disease 105

HeartRhythm

APRIL 30, 2024

Pulsed field ablation (PFA) is an emerging technology that applies high voltage electrical pulses to cardiac tissue selectively and induces cell death through predominately non-thermal irreversible electroporation.

Ablation 40

Ablation Arrhythmia Technology Pulmonary 40

DAIC

FEBRUARY 2, 2024

GE HealthCare’s latest Prucka 3 with CardioLab EP Recording system builds on more than twenty years of success in the field of electrophysiology to provide a robust ecosystem of mapping technologies that help provide accurate, efficient, and advanced analytics for the diagnosis and treatment of cardiac arrhythmias.

Electrophysiology 101

Electrophysiology Innovation AFIB Atrial Fibrillation 101

Journal of Cardiovascular Electrophysiology

MARCH 19, 2025

Compared to other available technologies, the usage of a stable, low-pressure cryoballoon (POLARx, Boston Scientific) has demonstrated lower nadir temperatures and longer thawing times. The aim of the POLAR ICE Study was to evaluate 1-year efficacy and safety outcomes of cryoballoon ablation in patients with paroxysmal atrial fibrillation.

Atrial Fibrillation 40

Atrial Fibrillation Myocardial Infarction Pulmonary Technology 40

DAIC

JULY 8, 2024

The “ MANIFEST-17K ” international study is the first to show important safety outcomes in a large patient population, including no significant risk of esophageal damage, with PFA. PFA is the latest ablation modality approved by the Food and Drug Administration that can be used to restore a regular heartbeat. and Harry B. and Harry B.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Pulmonary Heart Rhythm 105